Retatrutide Drug Information

Retatrutide - Overview

Retatrutide is a drug that is under investigated for weight loss. Retatrutide is not approved by the FDA and is not available in the US market at this time.

What Is Retatrutide Used For?

Retatrutide, sometimes referred to as LY3437943, is an investigational drug. Retatrutide belongs to a new class of medications that combine glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 (GLP-1) and glucagon.

Retatrutide - Dosage and Cost

Dosage and cost information for the retatrutide prescription drug candidate is not available at this time.

Retatrutide And Weight Loss

Retatrutide, similar to orforglipron, is under investigation for use in weight loss. In one phase 2 trial, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight. Retatrutide will likely be a once-weekly injection and is similar to drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Retatrutide targets GLP-1 receptors and two other hormones known as glucagon and glucose-dependent insulinotropic polypeptide (GIP). Due to these actions, retatrutide is sometimes referred to as a "triple G" (GGG) or tri-agonist drug.

Can I Buy Retatrutide Online?

Retatrutide prescription medication is not approved in the United States and, as such is not available at this time. It is not recommended that anyone try to buy retatrutide online, either.

Retatrutide - Side Effects

Retatrutide can cause side effects when used but, to date, is generally well tolerated. Retatrutide may cause adverse reactions such as an increased heart rate and tingling of the skin.

More Retatrutide Information

• Retatrutide - NEJM